Why the study?
Does long-term anticoagulant therapy reduce the incidence of thromboembolic episodes in patients with previous thromboembolic complications?
Does long-term anticoagulant therapy reduce the incidence of thromboembolic episodes in patients with previous thromboembolic complications?
Long-term outpatient anticoagulant therapy is feasible and reduces recurrent thromboembolic episodes when adequately monitored.
Supports monitored long-term anticoagulation feasibility in recurrent thromboembolism; leaves open randomized confirmation of benefit.
Experience with long-term anticoagulant therapy during the past seven years has been summarized. This report is based on the records of 227 individuals treated as private or outpatient clinic patients for from four weeks to seven years. Where adequate laboratory facilities are available outpatient long-term therapy may be satisfactorily controlled by physicians familiar with the use of anticoagulant drugs. Their correct use will lessen the incidence of thromboembolic episodes in patients who have previously suffered from such complications.
No takes yet. Share an insight, caveat, or question.
Tulloch et al. (1954) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: